Mimedx Group Inc (MDXG)

$6.76 +0.12 (1.81%)
Market Cap 982.45M
Revenue (ttm) 348.88M
Net Income (ttm) 42.42M
EPS (ttm) N/A
PE Ratio 22.40
Forward PE 23.58
Profit Margin 12.16%
Debt to Equity Ratio 0.01
Volume 529,600
Avg Vol 554,366
Day's Range N/A - N/A
Shares Out 147.96M
Stochastic %K 77%
Beta 1.73
Analysts Strong Sell
Price Target $12.20

Company Profile

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techni...

Industry: Biotechnology
Sector: Healthcare
Phone: 770 651 9100
Address:
1775 West Oak Commons Court, NE, Marietta, United States
jmdaddy
jmdaddy Oct. 25 at 4:23 PM
$MDXG Hopefully someone ask for updates on Japan and lawsuits. Hint...Hint. Just small investor who will be working like many others here.
0 · Reply
Mobagri
Mobagri Oct. 24 at 7:56 PM
$MDXG if they don’t beat expectations this can drop to $5
0 · Reply
jmdaddy
jmdaddy Oct. 24 at 6:31 PM
$MDXG Thinking we will get another strong qtr. Should move stock price up some, probably not much until we can get some consistent volume.
0 · Reply
dawg1220
dawg1220 Oct. 24 at 2:35 PM
$MDXG death by paper cuts- just can’t catch a break
0 · Reply
Mobagri
Mobagri Oct. 24 at 2:21 PM
$MDXG take advantage of the bounce and rid this losing stock
0 · Reply
Mobagri
Mobagri Oct. 23 at 1:51 PM
$MDXG only stock that is down today. Insiders are getting out.
1 · Reply
Mobagri
Mobagri Oct. 23 at 1:47 PM
$MDXG still have time to get out before October 29th
0 · Reply
Mobagri
Mobagri Oct. 23 at 12:42 AM
$MDXG https://www.prnewswire.com/news-releases/ex-mimedx-employees-allege--mimedx-pressured-healthcare-providers-to-treat-wounded-veterans-diabetics-chronic-wound-sufferers-and-other-patients-with-medically-unnecessary-or-unsuitable-products-302245440.html This lawsuit is spreading like wildfire
3 · Reply
Mobagri
Mobagri Oct. 23 at 12:33 AM
$MDXG With new CMS ruling and stiff competition and expected revenue mimedyx fair value should be around $5/share. I warned you’ll
1 · Reply
RUDYRUDY
RUDYRUDY Oct. 22 at 11:19 PM
$MDXG Well, seems like CMS date now just a formality as we know the details from Buddy Carter’s bill. Lobbyists and politicians running everything.
0 · Reply
Latest News on MDXG
MIMEDX to Host Third Quarter 2025 Operating and Financial Results Conference Call on October 29

Oct 15, 2025, 8:00 AM EDT - 10 days ago

MIMEDX to Host Third Quarter 2025 Operating and Financial Results Conference Call on October 29

MIMEDX Announces Launch of EPIXPRESS®

Oct 6, 2025, 9:28 AM EDT - 19 days ago

MIMEDX Announces Launch of EPIXPRESS®

MIMEDX to Sponsor and Attend Symposium on Advanced Wound Care (SAWC) Fall

Sep 3, 2025, 8:00 AM EDT - 7 weeks ago

MIMEDX to Sponsor and Attend Symposium on Advanced Wound Care (SAWC) Fall

MIMEDX to Participate in Upcoming Investor Conferences

Aug 27, 2025, 8:00 AM EDT - 2 months ago

MIMEDX to Participate in Upcoming Investor Conferences

MiMedx Group, Inc. (MDXG) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 11:01 PM EDT - 3 months ago

MiMedx Group, Inc. (MDXG) Q2 2025 Earnings Call Transcript

MIMEDX Announces Record Second Quarter 2025 Operating and Financial Results

Jul 30, 2025, 4:01 PM EDT - 3 months ago

MIMEDX Announces Record Second Quarter 2025 Operating and Financial Results

MIMEDX Announces Strategic Collaboration with Vaporox, Inc.

Jul 30, 2025, 8:00 AM EDT - 3 months ago

MIMEDX Announces Strategic Collaboration with Vaporox, Inc.

MIMEDX to Host Second Quarter 2025 Operating and Financial Results Conference Call on July 30

Jul 16, 2025, 8:00 AM EDT - 3 months ago

MIMEDX to Host Second Quarter 2025 Operating and Financial Results Conference Call on July 30

MIMEDX Comments on Proposed Medicare Reimbursement Rule Changes for CY 2026

Jul 15, 2025, 9:15 AM EDT - 3 months ago

MIMEDX Comments on Proposed Medicare Reimbursement Rule Changes for CY 2026

MIMEDX to Present at the BofA Securities 2025 Healthcare Conference

May 6, 2025, 8:00 AM EDT - 6 months ago

MIMEDX to Present at the BofA Securities 2025 Healthcare Conference

MIMEDX Announces Publication of Health Economics Data in Mohs Micrographic Surgery (MMS)

May 5, 2025, 8:30 AM EDT - 6 months ago

MIMEDX Announces Publication of Health Economics Data in Mohs Micrographic Surgery (MMS)

MiMedx Group, Inc. (MDXG) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 9:52 PM EDT - 6 months ago

MiMedx Group, Inc. (MDXG) Q1 2025 Earnings Call Transcript

MIMEDX Announces First Quarter 2025 Operating and Financial Results

Apr 30, 2025, 4:01 PM EDT - 6 months ago

MIMEDX Announces First Quarter 2025 Operating and Financial Results

MIMEDX to Feature Growing Body of Clinical and Scientific Evidence at Upcoming Wound & Surgical-Focused Industry Conferences

Apr 10, 2025, 4:01 PM EDT - 7 months ago

MIMEDX to Feature Growing Body of Clinical and Scientific Evidence at Upcoming Wound & Surgical-Focused Industry Conferences

MIMEDX to Present at TD Cowen 45th Annual Health Care Conference

Feb 27, 2025, 8:00 AM EST - 8 months ago

MIMEDX to Present at TD Cowen 45th Annual Health Care Conference

MiMedx Group, Inc. (MDXG) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 10:50 PM EST - 8 months ago

MiMedx Group, Inc. (MDXG) Q4 2024 Earnings Call Transcript

MIMEDX Announces Fourth Quarter and Full Year 2024 Operating and Financial Results

Feb 26, 2025, 4:01 PM EST - 8 months ago

MIMEDX Announces Fourth Quarter and Full Year 2024 Operating and Financial Results

MIMEDX's Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDs

Nov 14, 2024, 9:15 AM EST - 1 year ago

MIMEDX's Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDs

MiMedx Group, Inc. (MDXG) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 9:38 PM EDT - 1 year ago

MiMedx Group, Inc. (MDXG) Q3 2024 Earnings Call Transcript

MIMEDX Announces Third Quarter 2024 Operating and Financial Results

Oct 30, 2024, 4:01 PM EDT - 1 year ago

MIMEDX Announces Third Quarter 2024 Operating and Financial Results

MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30

Oct 14, 2024, 8:00 AM EDT - 1 year ago

MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30

MIMEDX Points to The New York Times Article on the Vast Benefits of Placental Tissue

Oct 8, 2024, 4:01 PM EDT - 1 year ago

MIMEDX Points to The New York Times Article on the Vast Benefits of Placental Tissue

MIMEDX Showcases Leading Allograft Portfolio and Its Latest Scientific and Clinical Evidence at SAWC Fall

Oct 1, 2024, 4:01 PM EDT - 1 year ago

MIMEDX Showcases Leading Allograft Portfolio and Its Latest Scientific and Clinical Evidence at SAWC Fall

EX-MiMEDX EMPLOYEES ALLEGE MiMEDX "PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE PRODUCTS"

Sep 11, 2024, 1:03 PM EDT - 1 year ago

EX-MiMEDX EMPLOYEES ALLEGE MiMEDX "PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE PRODUCTS"

THIRD DEFENDANT FIGHTS BACK AGAINST MiMEDX, CLAIMING 'DISREPUTABLE AND UNLAWFUL BUSINESS PRACTICES'

Sep 4, 2024, 4:23 PM EDT - 1 year ago

THIRD DEFENDANT FIGHTS BACK AGAINST MiMEDX, CLAIMING 'DISREPUTABLE AND UNLAWFUL BUSINESS PRACTICES'

DEFENDANT FIGHTS BACK AGAINST MiMEDX "BLATANT INTIMIDATION" NON-COMPETE SUIT

Aug 26, 2024, 9:30 AM EDT - 1 year ago

DEFENDANT FIGHTS BACK AGAINST MiMEDX "BLATANT INTIMIDATION" NON-COMPETE SUIT

MiMedx Group, Inc. (MDXG) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 9:10 PM EDT - 1 year ago

MiMedx Group, Inc. (MDXG) Q2 2024 Earnings Call Transcript

MIMEDX Announces Launch of HELIOGEN™ Fibrillar Collagen Matrix

Jul 31, 2024, 4:02 PM EDT - 1 year ago

MIMEDX Announces Launch of HELIOGEN™ Fibrillar Collagen Matrix

MIMEDX Announces Second Quarter 2024 Operating and Financial Results

Jul 31, 2024, 4:01 PM EDT - 1 year ago

MIMEDX Announces Second Quarter 2024 Operating and Financial Results

MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature – Scientific Reports

Jul 22, 2024, 8:10 AM EDT - 1 year ago

MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature – Scientific Reports

MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer

Jun 26, 2024, 4:01 PM EDT - 1 year ago

MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer

MiMedx Group, Inc. (MDXG) Q1 2024 Earnings Call Transcript

Apr 30, 2024, 9:33 PM EDT - 1 year ago

MiMedx Group, Inc. (MDXG) Q1 2024 Earnings Call Transcript

MIMEDX Announces First Quarter 2024 Operating and Financial Results

Apr 30, 2024, 4:01 PM EDT - 1 year ago

MIMEDX Announces First Quarter 2024 Operating and Financial Results

MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30

Apr 16, 2024, 8:00 AM EDT - 1 year ago

MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30

MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing

Mar 20, 2024, 7:00 AM EDT - 1 year ago

MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing

MiMedx Group, Inc. (MDXG) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 8:46 PM EST - 1 year ago

MiMedx Group, Inc. (MDXG) Q4 2023 Earnings Call Transcript

MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results

Feb 28, 2024, 4:01 PM EST - 1 year ago

MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results

MIMEDX to Present at TD Cowen 44th Annual Health Care Conference

Feb 20, 2024, 8:00 AM EST - 1 year ago

MIMEDX to Present at TD Cowen 44th Annual Health Care Conference

MIMEDX to Host Fourth Quarter and Full Year 2023 Operating and Financial Results Conference Call on February 28

Feb 12, 2024, 8:00 AM EST - 1 year ago

MIMEDX to Host Fourth Quarter and Full Year 2023 Operating and Financial Results Conference Call on February 28

MIMEDX Announces Improved Capital Structure with New Senior Secured Credit Facilities and Debt Refinancing

Jan 22, 2024, 8:00 AM EST - 1 year ago

MIMEDX Announces Improved Capital Structure with New Senior Secured Credit Facilities and Debt Refinancing

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of MiMedx Group, Inc. (MDXG) on Behalf of Investors

Jan 12, 2024, 4:00 PM EST - 1 year ago

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of MiMedx Group, Inc. (MDXG) on Behalf of Investors

The Law Offices of Frank R. Cruz Announces Investigation of MiMedx Group, Inc. (MDXG) on Behalf of Investors

Jan 11, 2024, 12:54 PM EST - 1 year ago

The Law Offices of Frank R. Cruz Announces Investigation of MiMedx Group, Inc. (MDXG) on Behalf of Investors

MiMedx reports US FDA warning letter for Axiofill, shares drop

Dec 29, 2023, 7:01 PM EST - 1 year ago

MiMedx reports US FDA warning letter for Axiofill, shares drop

MIMEDX Provides AXIOFILL® Update & Reiterates 2023 Full Year Net Sales and Fourth Quarter Adjusted EBITDA Margin Outlook

Dec 29, 2023, 5:00 PM EST - 1 year ago

MIMEDX Provides AXIOFILL® Update & Reiterates 2023 Full Year Net Sales and Fourth Quarter Adjusted EBITDA Margin Outlook

MIMEDX Announces Conversion of Outstanding Series B Convertible Preferred Stock to Common Stock

Dec 28, 2023, 8:00 AM EST - 1 year ago

MIMEDX Announces Conversion of Outstanding Series B Convertible Preferred Stock to Common Stock

MIMEDX to Highlight Published Data at SAWC Fall

Nov 2, 2023, 8:00 AM EDT - 2 years ago

MIMEDX to Highlight Published Data at SAWC Fall

MiMedx Group, Inc. (MDXG) Q3 2023 Earnings Call Transcript

Oct 30, 2023, 9:17 PM EDT - 2 years ago

MiMedx Group, Inc. (MDXG) Q3 2023 Earnings Call Transcript

MIMEDX Announces Third Quarter 2023 Operating and Financial Results

Oct 30, 2023, 4:01 PM EDT - 2 years ago

MIMEDX Announces Third Quarter 2023 Operating and Financial Results

jmdaddy
jmdaddy Oct. 25 at 4:23 PM
$MDXG Hopefully someone ask for updates on Japan and lawsuits. Hint...Hint. Just small investor who will be working like many others here.
0 · Reply
Mobagri
Mobagri Oct. 24 at 7:56 PM
$MDXG if they don’t beat expectations this can drop to $5
0 · Reply
jmdaddy
jmdaddy Oct. 24 at 6:31 PM
$MDXG Thinking we will get another strong qtr. Should move stock price up some, probably not much until we can get some consistent volume.
0 · Reply
dawg1220
dawg1220 Oct. 24 at 2:35 PM
$MDXG death by paper cuts- just can’t catch a break
0 · Reply
Mobagri
Mobagri Oct. 24 at 2:21 PM
$MDXG take advantage of the bounce and rid this losing stock
0 · Reply
Mobagri
Mobagri Oct. 23 at 1:51 PM
$MDXG only stock that is down today. Insiders are getting out.
1 · Reply
Mobagri
Mobagri Oct. 23 at 1:47 PM
$MDXG still have time to get out before October 29th
0 · Reply
Mobagri
Mobagri Oct. 23 at 12:42 AM
$MDXG https://www.prnewswire.com/news-releases/ex-mimedx-employees-allege--mimedx-pressured-healthcare-providers-to-treat-wounded-veterans-diabetics-chronic-wound-sufferers-and-other-patients-with-medically-unnecessary-or-unsuitable-products-302245440.html This lawsuit is spreading like wildfire
3 · Reply
Mobagri
Mobagri Oct. 23 at 12:33 AM
$MDXG With new CMS ruling and stiff competition and expected revenue mimedyx fair value should be around $5/share. I warned you’ll
1 · Reply
RUDYRUDY
RUDYRUDY Oct. 22 at 11:19 PM
$MDXG Well, seems like CMS date now just a formality as we know the details from Buddy Carter’s bill. Lobbyists and politicians running everything.
0 · Reply
Monticello4
Monticello4 Oct. 22 at 10:25 PM
$ORGO Remember this post? FinancialScience - May 28, 2025 12:01 AM $MDXG any mdxg shareholder who does not swap their mdxg shares for orgo shares is a dummy Bearish Bbbbbbbbwwwwwwhahahahahahahahaha!!!!!!!!!!! 1
2 · Reply
RUDYRUDY
RUDYRUDY Oct. 22 at 7:13 PM
$MDXG Well, that appears to be a major blow to Mimedx. Once again, hosed by politicians. LCDs delayed again…
0 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Oct. 22 at 6:59 PM
$MDXG Cannot believe they will delay evidence based product exclusions for a year! Mimedx gets screwed again.
4 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Oct. 22 at 12:25 PM
$MDXG 23 days until CMS
0 · Reply
Monticello4
Monticello4 Oct. 21 at 7:07 PM
$MDXG
0 · Reply
Mobagri
Mobagri Oct. 21 at 3:13 PM
$MDXG great time to sell before end year.
0 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Oct. 21 at 12:28 PM
$MDXG 24 days till CMS. $8 by year end.
0 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Oct. 21 at 3:05 AM
$MDXG $8 by year end!
0 · Reply
Mobagri
Mobagri Oct. 21 at 2:59 AM
$MDXG
0 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Oct. 20 at 9:19 PM
$MDXG 25 days till CMS
1 · Reply
RUDYRUDY
RUDYRUDY Oct. 20 at 5:16 PM
$MDXG Few weeks till CMS. Lets gooooo!
0 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Oct. 19 at 2:54 PM
$MDXG 26 days till CMS
0 · Reply